Novartis: A long-term partner to the healthcare ecosystem, providing the sustained investment in oncology innovation, system readiness and partnership essential to improve cancer outcomes
Pembro, made by pharma giant MSD, is hailed as a drug that saves and prolongs lives but it comes at an exorbitant cost
Our cancer mortality rates are still 5.4 per cent higher than the EU average but have improved significantly in recent years
Recent controversial comments by Donald Trump and others have – at best – overstated any links between paracetamol use and rising autism diagnoses
Colleagues described him as an inspirational and visionary leader with a strong intellect
Only one in four of 56 new cancer treatments licensed since 2020 available in Ireland, leading to ‘inferior treatment options’
Six years after a shock melanoma diagnosis, Miriam Staunton is currently free of cancer and advocating for other patients
Industry and Government keep urging each other to do more but neither is moving to fill in the gaps
Former international cricketer Emma Beamish on living with the anxiety of never knowing when it might strike again, and her decision not to have children
The approval for the public system is a long process, entailing between 20 and 30 steps
Pharma sector stakeholders still scoring points off each other despite new resources and talk of ‘shared purpose’
Dr Muiris Houston: Drugs used to treat epilepsy and bipolar disorder linked to neurodevelopmental disorders in patients’ children
Icon has developed Cassandra AI which predicts likely post-marketing requirements
Newly updated Moderna and Pfizer vaccines are targeted towards dominant strains of virus
Warning comes amid shortcomings in the system for approving new medicines
Public patients may now have to wait up to two years longer than all private patients for access to innovative therapies
European health officials have advocated portfolio diversity to help fight different variants
Move also aims to encourage research into neglected treatments
Half of all applications for first new-generation treatment for weight loss refused due to strict criteria
Will I have to spend years of my life fighting for the HSE to fund life-changing treatment while this disease eats away at me?
Refusal of strategy to be published this week to address pricing issues for common off-patent therapies likely only to worsen supply issues
Mayor rejects suggestion the erotic centre would have any impact on the safety of the medicines agency or its staff
Up to 1,250 children could experience some form of neurodevelopmental delay as a result of exposure to valproate in utero - HSE report
Business Today: the best news, analysis and comment from The Irish Times business desk
Nasal sprays, asthma inhalers and eye drops the latest to experience shortages in Irish market, says Azure Pharma
Emer Cooke says the situation was ‘unique’ and measures are being taken to avoid a repeat next winter
Attempts to make Paxlovid more freely available have so far not resulted in a significant uptake of the treatment
Surge in demand this winter puts pressure on supplies amid sharp disagreement over long-term impact of pricing
Government urged to secure supply of the breakthrough treatment as soon as possible
Adapted boosters to be available within days following recommendation by EMA
Separate shots developed by rivals Moderna and Pfizer-BioNTech are now set for EC approval
Authorisation in European Union for Omicron-specific vaccines expected next month
Depending on your age group and level of vulnerability, you may be set for a jab in autumn as infection threats intensify
ECDC and EMA say there is ‘no clear evidence’ to support wider second booster campaign
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices
